Elephas Biosciences Strengthens Scientific and Clinical Leadership As Company Advances Toward Commercial Availability of Its Live-Tumor Immunology Platform

MADISON, Wis., January 8, 2025 – Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today the expansion of its scientific and clinical leadership with the appointments of Premal Patel, MD, PhD, as Chief Medical Officer and Dr. Michael Giordano to the company’s Scientific Advisory Board. These significant additions follow Elephas’ recent peer-reviewed publication in the Journal of Translational Medicine , the close of a $42 million financing round, and continued commercial growth wit